Navigation Links
Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France
Date:3/15/2012

system by the Institut Gustave Roussy, uncertainties relating to future initial launch and training agreements with other cancer centers in Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to refle
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... at the Morgan Stanley Global Healthcare Conference on Thursday, ... Nevro management is scheduled to present at 11:45 ... live audio webcast, accessible in the "Investors" section of ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has announced the ... - By Packaging type, Regions and Vendors - Market ... their offering. The growth of Medical ... use industry, i.e., Medical devices industry. More innovations are ... as to be tamper evident, and child-resistant. The industry ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Raloxifene Market, ... to the statistics, over 200 million people suffer from ... above in China , 50% have ... 30%-50% among women aged 60 and above. Raloxifene ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Investigation Report on China's Raloxifene Market, 2015-2019 2
... Feb. 15, 2011 Baxano, Inc. ( w w ... om ) today announced the addition of George A. Harter, ... Officer, Mr. Harter will be responsible for Finance, Administration and Human ... for Acclarent, Inc. from 2005 to 2011, through its acquisition by ...
... 2011 Takeda Pharmaceuticals International, Inc., a wholly-owned ... that its Pharmaceutical Development Division has entered into ... ) and Quintiles, two of the world,s largest ... of the agreements, Covance and Quintiles will work ...
Cached Medicine Technology:Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer 2Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles 2
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, an Elliot ... healthcare solutions organization, to provide electronic medical record (EMR) consulting services to Amerinet ... will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit ... with Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for warm ... DriButts plans to bring 600 DriButts Diapers to rural areas of Haiti during ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... care community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado ... 2016, and has been carefully designed to serve up to 80 people living ...
(Date:9/3/2015)... ... 03, 2015 , ... Today, Splashtop announced availability of its ... of the LANDESK One Partner program. Splashtop remote desktop solutions complement ... experience in remote access and control:, , LANDESK customers ...
(Date:9/3/2015)... ... 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project will ... Kate Road in Monroe, North Carolina. The event food will be provided ... Kate Clyde’s offers off-premise catering and event services from casual to elegant. They are ...
Breaking Medicine News(10 mins):Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2
... The "Get Your Head in the Game(R)" Awareness Walk held ... Brain Tumor Foundation (KHG), the only organization in the US ... tumors. (Photo: http://www.newscom.com/cgi-bin/prnh/20090505/PH11172 ... major sponsors also moves KHG ( www.khgfoundation.com ) ...
... System Warns that Snake Bites are Becoming More Powerful and ... in weather marks a change in rattlesnake behavior as well. ... not poisonous, the rattlesnake is. In humans, a rattlesnake ... fatal. "Over the past couple of years we have seen ...
... HARBOR, N.Y. (May 5, 2009) The ... provide a supportive yet flexible framework that allows vertebrates ... knowledge about the vertebrate skeleton, especially recent research on ... a new monograph, The Skeletal System . ...
... /PRNewswire/ - Medical device company, Intelligent Hospital ... agreement with the South Korean pharmacy application ... Seoul. Daeiltech will provide direct sales and ... (Robotic IV Automation) across South Korea. , ...
... VIEW, Calif., May 5 As early diagnosis ... survival, and better quality of life for patients, ... for primary care. Innovative molecular technologies have generated ... new market entrants. These efforts will go a ...
... Serve as Honorary Co-chair of EventBALTIMORE, May 5 The ... Reeves, former lead singer of the Motown group Martha and ... for the organization,s fundraising walk-a-thon event. The third annual ... will take place on the morning of July 6, 2009, ...
Cached Medicine News:Health News:Walk Raises Almost $200,000 to Heighten Brain Tumor Awareness 2Health News:As the Weather Warms Up Rattlesnakes Come Out to Enjoy the Sun Just as Californians Do 2Health News:New book summarizes current knowledge on the biology of the vertebrate skeleton 2Health News:IH Systems Extends Global Reach into South Korean Medical Device Market 2Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 2Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 3Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 4Health News:Martha Reeves to Participate in the National Federation of the Blind Motor City March for Independence 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: